Melanoma Prognosis and Staging

Emily Z. Keung; Charles M. Balch; John F. Thompson; John M. Kirkwood; Richard A. Scolyer; Vernon K. Sondak; Jeffrey E. Gershenwald

doi:10.1007/978-3-030-05070-2_4

Melanoma Prognosis and Staging

Emily Z. Keung, Charles M. Balch, John F. Thompson, John M. Kirkwood, Richard A. Scolyer, Vernon K. Sondak, Jeffrey E. Gershenwald

Surgical Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

A standardized, uniformly accepted cancer staging system is an essential and fundamental equirement for meaningful comparisons to be made across patient populations. In the case of melanoma, the identification of increasingly powerful prognostic factors has led to sequential modifications of the cutaneous melanoma staging system. The American Joint Committee on Cancer (AJCC) Melanoma Expert Panel significantly revised the melanoma staging system in 2017, and the current eighth edition AJCC melanoma staging system is the most widely accepted approach to melanoma staging and classification. This chapter reviews the prognostic factors relevant to current melanoma practice with an emphasis on factors that have significance in contemporary statistical analyses, using the eighth edition AJCC melanoma staging system and an international database analysis as a framework.

Original language	English (US)
Title of host publication	Cutaneous Melanoma, Sixth Edition
Publisher	Springer International Publishing
Pages	271-297
Number of pages	27
Volume	1
ISBN (Electronic)	9783030050702
ISBN (Print)	9783030050689
DOIs	https://doi.org/10.1007/978-3-030-05070-2_4
State	Published - Jan 1 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-05070-2_4

Cite this

@inbook{eed67aca11004620877aeac5f58388b4,

title = "Melanoma Prognosis and Staging",

abstract = "A standardized, uniformly accepted cancer staging system is an essential and fundamental equirement for meaningful comparisons to be made across patient populations. In the case of melanoma, the identification of increasingly powerful prognostic factors has led to sequential modifications of the cutaneous melanoma staging system. The American Joint Committee on Cancer (AJCC) Melanoma Expert Panel significantly revised the melanoma staging system in 2017, and the current eighth edition AJCC melanoma staging system is the most widely accepted approach to melanoma staging and classification. This chapter reviews the prognostic factors relevant to current melanoma practice with an emphasis on factors that have significance in contemporary statistical analyses, using the eighth edition AJCC melanoma staging system and an international database analysis as a framework.",

author = "Keung, {Emily Z.} and Balch, {Charles M.} and Thompson, {John F.} and Kirkwood, {John M.} and Scolyer, {Richard A.} and Sondak, {Vernon K.} and Gershenwald, {Jeffrey E.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-05070-2_4",

language = "English (US)",

isbn = "9783030050689",

volume = "1",

pages = "271--297",

booktitle = "Cutaneous Melanoma, Sixth Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Melanoma Prognosis and Staging

AU - Keung, Emily Z.

AU - Balch, Charles M.

AU - Thompson, John F.

AU - Kirkwood, John M.

AU - Scolyer, Richard A.

AU - Sondak, Vernon K.

AU - Gershenwald, Jeffrey E.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - A standardized, uniformly accepted cancer staging system is an essential and fundamental equirement for meaningful comparisons to be made across patient populations. In the case of melanoma, the identification of increasingly powerful prognostic factors has led to sequential modifications of the cutaneous melanoma staging system. The American Joint Committee on Cancer (AJCC) Melanoma Expert Panel significantly revised the melanoma staging system in 2017, and the current eighth edition AJCC melanoma staging system is the most widely accepted approach to melanoma staging and classification. This chapter reviews the prognostic factors relevant to current melanoma practice with an emphasis on factors that have significance in contemporary statistical analyses, using the eighth edition AJCC melanoma staging system and an international database analysis as a framework.

AB - A standardized, uniformly accepted cancer staging system is an essential and fundamental equirement for meaningful comparisons to be made across patient populations. In the case of melanoma, the identification of increasingly powerful prognostic factors has led to sequential modifications of the cutaneous melanoma staging system. The American Joint Committee on Cancer (AJCC) Melanoma Expert Panel significantly revised the melanoma staging system in 2017, and the current eighth edition AJCC melanoma staging system is the most widely accepted approach to melanoma staging and classification. This chapter reviews the prognostic factors relevant to current melanoma practice with an emphasis on factors that have significance in contemporary statistical analyses, using the eighth edition AJCC melanoma staging system and an international database analysis as a framework.

UR - http://www.scopus.com/inward/record.url?scp=85132358638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132358638&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-05070-2_4

DO - 10.1007/978-3-030-05070-2_4

M3 - Chapter

AN - SCOPUS:85132358638

SN - 9783030050689

VL - 1

SP - 271

EP - 297

BT - Cutaneous Melanoma, Sixth Edition

PB - Springer International Publishing

ER -

Melanoma Prognosis and Staging

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this